NEPHROS, INC. Defined Contribution Plan, Cost
NEPHROS, INC. (NEPH) reported Defined Contribution Plan, Cost of $52.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2019-03-12
- NEPHROS, INC. defined contribution plan, cost for fiscal 2018 was $52.00K, a 33.33% increase from fiscal 2017.
- NEPHROS, INC. defined contribution plan, cost for fiscal 2017 was $39.00K, a 11.36% decline from fiscal 2016.
- NEPHROS, INC. defined contribution plan, cost for fiscal 2016 was $44.00K, a 4.76% increase from fiscal 2015.
- NEPHROS, INC. defined contribution plan, cost for fiscal 2015 was $42.00K, a 2.33% decline from fiscal 2014.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2018-12-31 | $52.00K 10-K · filed 2019-03-12 |
| 2017-12-31 | $39.00K 10-K · filed 2019-03-12 |
| 2016-12-31 | $44.00K 10-K · filed 2018-02-26 |
| 2015-12-31 | $42.00K 10-K · filed 2017-03-20 |
| 2014-12-31 | $43.00K 10-K · filed 2016-03-30 |
| 2013-12-31 | $46.00K 10-K · filed 2015-04-15 |
| 2012-12-31 | $49.00K 10-K · filed 2014-03-28 |
| 2011-12-31 | $28.00K 10-K · filed 2013-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |